Skip to main content
You are using an older version of Internet Explorer that is not supported by Please upgrade for the best experience.

Vinay Rathi, M.D.

Rathi Originally from Reston, Virginia, Dr. Vinay Rathi studied anthropology in the Medicine and Society Program as an undergraduate at Washington University in St. Louis, where he served as a class marshal at graduation. He then matriculated at the Yale School of Medicine, where he was awarded the Samuel Jordan Graham Scholarship in Academic Surgery and the William U. Gardner Prize for the most outstanding thesis in his graduating class. While in medical school, he worked at McKinsey & Company and the Center for Outcomes Research and Evaluation (CORE). His work has been published in JAMA and the BMJ.

For more information on Dr. Rathi, check out his Harvard Catalyst website and Google Scholar page.


Undergraduate School
Washington University in St. Louis (Anthropology)

Medical School
Yale School of Medicine


The FDA 515 initiative: Addressing the evidence gap for high-risk cardiovascular devices? Rathi VK, Kesselheim AS, Ross JS. JAMA Cardiology. 2016 May 1. 1(2):117-8.

Publication of clinical studies supporting FDA premarket approval for high-risk cardiovascular devices between 2011 and 2013: A cross-sectional study. Phillips AT, Rathi VK, Ross JS. JAMA Intern Med. 2016 Apr 1. 176(4):551-2.

How do orthopaedic devices change after their initial FDA premarket approval? Samuel AM, Rathi VK, Grauer JN, Ross JS. Clin Orthop Relat Res. 2016 Apr. 474(4):1053-68.

Characteristics of clinical studies conducted over the total product life cycle of high-risk therapeutic medical devices receiving FDA premarket approval in 2010 and 2011. Rathi VK, Krumholz HM, Masoudi FA, Ross JS. JAMA. 2015 Aug 11. 314(6):604-12.

Orthopaedic surgeons receive the most industry payments to physicians but large disparities are seen in sunshine act data. Samuel AM, Webb ML, Lukasiewicz AM, Bohl DD, Basques BA, Russo GS, Rathi VK, Grauer JN. Clin Orthop Relat Res. 2015 Oct. 473(10):3297-306.

Postmarket modifications of high-risk therapeutic devices in otolaryngology cleared by the US Food and Drug Administration. Rathi VK, Ross JS, Samuel AM, Mehra S. Otolaryngol Head Neck Surg. 2015 Sep. 153(3):400-8.

Industry ties in otolaryngology: Initial insights from the physician payment sunshine act. Rathi VK, Samuel AM, Mehra S. Otolaryngol Head Neck Surg. 2015 Jun. 152(6):993-9.

Predictors of clinical trial data sharing: Exploratory analysis of a cross-sectional survey. Rathi VK, Strait KM, Gross CP, Hrynaszkiewicz I, Joffe S, Krumholz HM, Dzara K, Ross JS. Trials. 2014 Oct 2. 15:384.

Association of genes with physiological functions by comparative analysis of pooled expression microarray data. Chen IB, Rathi VK, DeAndrade DS, Jay PY. Physiol Genomics. 2013 Jan 15. 45(2):69-78.

Sharing of clinical trial data among trialists: A cross sectional survey. Rathi V, Dzara K, Gross CP, Hrynaszkiewicz I, Joffe S, Krumholz HM, Strait KM, Ross JS. BMJ. 2012. 2012;345:e7570.